Injury severity, age, metabolic health, protein intake, sleep quality, training load, inflammation, and rehabilitation strategy all matter
Pretreatment without peptides was used as a negative control, while treatment with an anti-aging peptide, acetyl hexapeptide-8 (Wrinklend), was taken as a positive control
Should the calculated median fall between two observed allowed amounts, the median allowed amount is the next highest observed value
Diabetologia 57(4):781784 Bray JJH, Foster-Davies H, Salem A, Hoole AL, Obaid DR, Halcox JPJ et al (2021) Glucagon-like peptide-1 receptor agonists improve biomarkers of inflammation and oxidative stress: a systematic review and meta-analysis of randomised controlled trials
The endotoxin data is clean and the HPLC traces are textbook-quality. First order from this supplier pleasantly surprised by how professional the process was
NAD+ vs NMN vs NR (and IV vs SubQ) NAD+ Delivery Comparison Feature Mechanism NAD+ Injection (SubQ) Direct coenzyme delivery NAD+ Infusion (IV) Direct coenzyme delivery Oral NMN NAD+ precursor (converted in vivo) Oral NR (Niagen) NAD+ precursor (converted in vivo) Feature Typical research-planning dose NAD+ Injection (SubQ) 50-100 mg, 2-3x/week NAD+ Infusion (IV) 250-1,000 mg per session Oral NMN 300-600 mg/day Oral NR (Niagen) 300-1,000 mg/day Feature Speed to systemic NAD+ rise NAD+ Injection (SubQ) Hours NAD+ Infusion (IV) Minutes to hours Oral NMN Days to weeks Oral NR (Niagen) Days to weeks Feature Strongest human evidence NAD+ Injection (SubQ) Limited NAD+ Infusion (IV) Pilot PK and historical case reports Oral NMN Growing RCT base Oral NR (Niagen) Strongest RCT base Feature Convenience NAD+ Injection (SubQ) At-home injection technique required NAD+ Infusion (IV) Clinic visit, 2-4 hour infusion Oral NMN Daily oral capsule Oral NR (Niagen) Daily oral capsule Feature Regulatory status NAD+ Injection (SubQ) Not FDA-approved
